Investing

How Is Digital Behavioral Health Navigating Consolidation?
Business How Is Digital Behavioral Health Navigating Consolidation?

The landscape of digital behavioral health has undergone a profound transformation, moving away from the speculative fervor that once defined its early growth to a more structured, clinical approach that prioritizes long-term patient outcomes and operational sustainability. This shift represents a

Can Thesis Care Scale Clinical Capacity With $45M in Funding?
Process Can Thesis Care Scale Clinical Capacity With $45M in Funding?

The modern medical infrastructure is currently buckling under the weight of an aging population and a dwindling supply of qualified clinicians who are increasingly leaving the profession due to administrative fatigue. As patient needs become more complex, traditional health systems find themselves

Is Healthcare AI Regulation Still a Wild West?
Public Policy Is Healthcare AI Regulation Still a Wild West?

The transition from human-only clinical oversight to algorithm-assisted decision-making has occurred with such velocity that traditional legal safeguards now appear to be running several miles behind the technology they are meant to govern. While patients and providers increasingly rely on

Lantern Secures $30 Million to Expand Specialty Care Platform
Business Lantern Secures $30 Million to Expand Specialty Care Platform

As the financial burden of complex medical treatments continues to escalate, American employers are increasingly seeking sophisticated digital solutions that can navigate the labyrinthine healthcare landscape without sacrificing clinical quality for their workforce. This demand has culminated in a

Prestige Consumer Healthcare Acquires Breathe Right for $1.05 Billion
Business Prestige Consumer Healthcare Acquires Breathe Right for $1.05 Billion

The landscape of domestic medicine cabinets is undergoing a silent but profound transformation as consumers increasingly bypass traditional pills in favor of mechanical, drug-free solutions that promise fewer side effects and immediate relief. This shift has culminated in the landmark announcement

Can Gilead Reset the Future of Autoimmune Therapy?
Care Can Gilead Reset the Future of Autoimmune Therapy?

The pharmaceutical industry is currently witnessing a tectonic shift as researchers move away from merely dampening overactive immune systems toward a radical process known as the "immune reset." Gilead Sciences has signaled its commitment to this frontier by executing a $1.7 billion

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later